Medical Pharmaceuticals Headlines from PR Newswire

Forces of Change Reshaping Corporate Libraries & Information Services
Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace
Bay Area Pain Medical Associates Issues Important Security and Protection Notification
Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020
Parasites beware; National Center for Veterinary Parasitology at Oklahoma State University has its eyes on you
Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
Slow Walking Speed and Memory Complaints Can Predict Dementia
Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon
ScriptPro and TCGRx Integrate Pharmacy Automation Technologies
GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois
Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development
The Hepatitis C virus is the main cause of liver transplant in the world
Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy
Alere Inc. Schedules Conference Call for 8:30 a.m. ET August 4, 2014 to Discuss Second Quarter 2014 Results English
Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
Support for SAVE Medicare Home Health Act Mounts
Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile
Solanbridge Group Inc Announces Acquisition of
Syneron Announces Investor Meeting Focused on UltraShape U.S. Launch Update on September 17, 2014
ConvaTec Introduces DEHP-Free UnoMeter™ Safeti™ Plus Urine Meter English
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers
Xybion Announces It Will Host International User Conference in Philadelphia
Semler Reports Second Quarter 2014 Financial Results
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
Galmed Pharmaceuticals Reports First Half 2014 Financial Results
AbbVie Reports Second-Quarter 2014 Financial Results
CPhI South America 2014 Launches with Generics Showing Huge Growth
IDEXX Laboratories Announces Second Quarter Results
Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™
Butterfly Health Launches Accidental Bowel Leakage (ABL) Educational Initiative with National Association for Continence (NAFC)
Is Europe Putting Cancer Research at Risk?
Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results
Analysis of Human Gut Microbiome Provides New Opportunities for Liver Cirrhosis Diagnosis and Treatment
Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer
AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
Mommy Makeovers on the Rise
Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
Endo completes acquisition of Grupo Farmaceutico Somar® English
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
IGI Laboratories Announces Second Quarter 2014 Results
IGI Laboratories, Inc. Announces Change To Its Board Of Directors
Uroplasty Reports Fiscal First Quarter Results
Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2014
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015
QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline
Amgen Announces Webcast of 2014 Second Quarter Financial Results

< Prev Next >
PR Newswire - United Business Media